EVP Oncology and Immunology
Codagenix Inc.
Cambridge, MA, United States
Dr. Johanna Kaufmann is Executive Vice President of Oncology and Immunoloy at Codagenix. She is a scientific and strategic leader in immuno-oncology, immunology and virology with broad expertise across preclinical and translational drug development. Before joining Codagenix in 2021, she was a Scientific Director at GSK, leading an immune biology group and supporting progression of multiple portfolio assets as part of the immuno-oncology senior leadership team. She previously led mechanisms of action studies for immuno-oncology assets at TESARO and headed three preclinical herpes virus vaccine programs at Genocea Biosciences. Dr. Kaufmann earned a MS in Molecular Medicine from Friedrich-Alexander University in Erlangen, Germany, and a PhD in Cancer Virology from the German Cancer Research Center (DKFZ) and Heidelberg University, Germany.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Friday, October 13, 2023
2:33 PM – 2:45 PM US ET